All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Fungal metabolite IM502 reprograms tumor-associated macrophages to enhance anti-cancer immunity

By

Yan Li4 Send email to [email protected]

12h ago· 78 min readenNews

Summary

Researchers developed an exogenous precursor-assisted fungal metabolite (ePAFM) strategy to generate bioactive fungal metabolites, identifying IM502—a meroterpenoid-like compound—as a potent modulator of tumor-associated macrophages (TAMs). IM502 works by inhibiting PI3Kγ and redirecting STAT signaling from STAT3/6 to STAT1/2 dominance, reversing TAM-mediated immunosuppression. This reprogramming of macrophages potently activates anti-tumor immunity, suppresses cancer growth and metastasis, and overcomes resistance to checkpoint blockade immunotherapy, revealing a promising new approach for cancer treatment.

Source

bskyFungal metabolite IM502 reprograms tumor-associated macrophages to enhance anti-cancer immunitycell.com

Key quotes

· 3 pulled
Hu et al. discover a fungal metabolite, IM502, that re-educates immunosuppressive cells inside tumors.
By reprogramming macrophages, IM502 potently activates anti-tumor immunity, suppresses cancer growth and metastasis, and overcomes resistance to checkpoint blockade.
IM502 primarily inhibits PI3Kγ and redirects STAT signaling from STAT3/6 to STAT1/2 dominance, thereby reversing TAM-mediated immunosuppression.
Snippet from the RSS feed
Hu et al. discover a fungal metabolite, IM502, that re-educates immunosuppressive cells inside tumors. By reprogramming macrophages, IM502 potently activates anti-tumor immunity, suppresses cancer growth and metastasis, and overcomes resistance to checkpo

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.